AstraZeneca treatment unsuccessful at preventing symptomatic COVID-19
AstraZeneca’s antibody treatment – AZD7442 – has been unsuccessful in preventing symptomatic COVID-19 in patients recently exposed to the SARS-CoV-2 virus.
The results of AstraZeneca’s...
Rise in cost and usage of antidepressants sparks concern
An alarming surge in the usage and cost of antidepressants in 2020 has been recorded by researchers from the University of Huddersfield.
Researchers conducted a...
Study finds Opioid Agonist Therapy lowers mortality risk
Opioid Agonist Therapy (OAT) can lower the risk of death amongst people with opioid dependence, findings from a global review have shown.
The review was...
Study demonstrates long-lasting efficacy of COVID-19 vaccine programme
Researchers carrying out pre-clinical testing of a COVID-19 vaccine programme have discovered a high antibody response, lasting over 18 weeks.
Biotechnology company Defence Therapeutics Inc...
Digital tool will reduce the cost of developing new medicines
A new digital tool is being rolled out in the UK that will make developing medicines cheaper, safer, and faster.
In a vital step for...
Mild myocarditis reported with COVID-19 mRNA vaccines
Cases of mild myocarditis are being reported in people who have been vaccinated with the COVID-19 mRNA vaccines.
Myocarditis is an inflammation of the heart...
Cancer vaccine shows long-lasting anti-tumoural response
A pre-clinical study has demonstrated the anti-tumoural efficacy of the AccuVAC-D001 cancer vaccine.
Developed by biotechnology company Defence Therapeutics Inc., the AccuVAC-D001 cancer vaccine demonstrated...
Study shows newborns with seizures may be overmedicated
A new study has shown that babies on long-term antiseizure medication may be overmedicated, as continued administration of the medicines may not prevent continued...
Major progress made to improve Parkinson’s disease treatment
Scientists have made a breakthrough in the development of a nasal spray for Parkinson’s disease treatment.
Researchers from the University of York have developed a...
Exploring vaccine storage and delivery
HEQ speaks with Thomas Sorensen, Senior Manager at UNICEF, about the cold chain and the challenges facing vaccine refrigeration.
Global charity UNICEF has been delivering...
Refrigeration and the vaccine cold chain
HEQ speaks with AREA President Marco Buoni about the role of refrigeration and the cold chain in combating the COVID-19 pandemic.
The cold chain is...
Improved treatment for miscarriage more cost-effective for NHS
A new drug combination that is better at treating ‘silent’ miscarriages than the currently used NHS treatment is more cost-effective, according to a new...
Cutting-edge UK lab to fast-track COVID-19 variant vaccines
A new state-of-the-art lab in the UK will test the effectiveness of vaccines against new variants of COVID-19.
The new testing lab based at Porton...
MHRA gives green light to cardiovascular treatment
The Medicines and Healthcare products Regulatory Agency has authorised Vazkepa to reduce cardiovascular risk in statin-treated adult patients who have elevated triglycerides and other...
COVID-19 vaccine response dampened by IBD drug infliximab
A new study has shown that people who take a common drug for inflammatory bowel disease (IBD) have a dampened immune response to the...
From allergy vaccines to COVID-19 Nabs with Angany Inc
Angany Inc is an emerging Franco-Canadian pharmaceutical company which aims to bring new hope to people suffering from allergies.
The word ‘angani’ means ‘open horizons’...
Global failure to tackle urgent threat of antibiotic resistance
A new report from the World Health Organization (WHO) has highlighted the ongoing global failure to develop desperately needed antibacterial treatments despite growing awareness...
Those with prior COVID-19 infection have boosted immune response
A new study has shown that people who have previously contracted COVID-19 have significantly higher T cell and antibody responses following a single dose...
Ultra-low temperature storage and the vaccine cold chain
Mikael Hoier, CEO of cold storage manufacturer Lowenco, speaks with HE about innovation in low-temperature vaccine storage.
Danish manufacturer Lowenco is an international leader in...
Fourth COVID-19 vaccine authorised for use in Europe
The European Commission has granted conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Janssen Pharmaceutica NV., one of the Janssen Pharmaceutical Companies...
